Cipher Pharmaceuticals Inc.
CPHRF
$12.09
-$0.47-3.74%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.45M | 50.06M | 47.59M | 39.52M | 33.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.45M | 50.06M | 47.59M | 39.52M | 33.36M |
| Cost of Revenue | 10.03M | 12.85M | 12.48M | 11.08M | 9.26M |
| Gross Profit | 40.42M | 37.20M | 35.12M | 28.43M | 24.10M |
| SG&A Expenses | 16.30M | 17.47M | 18.36M | 15.59M | 12.24M |
| Depreciation & Amortization | 7.23M | 6.94M | 7.07M | 5.55M | 4.02M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.59M | 37.28M | 37.92M | 32.25M | 25.52M |
| Operating Income | 16.87M | 12.77M | 9.67M | 7.27M | 7.85M |
| Income Before Tax | 17.16M | 9.70M | 5.76M | 1.87M | 2.96M |
| Income Tax Expenses | -10.17M | -7.67M | -6.38M | -7.37M | -8.59M |
| Earnings from Continuing Operations | 27.33 | 17.36 | 12.14 | 9.25 | 11.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.33M | 17.36M | 12.14M | 9.25M | 11.55M |
| EBIT | 16.87M | 12.77M | 9.67M | 7.27M | 7.85M |
| EBITDA | 23.81M | 19.53M | 16.56M | 12.64M | 11.69M |
| EPS Basic | 1.07 | 0.68 | 0.47 | 0.37 | 0.47 |
| Normalized Basic EPS | 0.42 | 0.26 | 0.20 | 0.12 | 0.15 |
| EPS Diluted | 1.04 | 0.66 | 0.46 | 0.36 | 0.46 |
| Normalized Diluted EPS | 0.41 | 0.25 | 0.20 | 0.12 | 0.14 |
| Average Basic Shares Outstanding | 102.45M | 102.58M | 102.38M | 100.62M | 99.00M |
| Average Diluted Shares Outstanding | 104.76M | 104.38M | 104.13M | 102.19M | 100.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |